Skip to main content

Want a detailed portfolio tracker?

Amylyx Pharmaceuticals (AMLX) Income Statement (2021 - 2026)

Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Amylyx Pharmaceuticals (AMLX).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
Revenue and COGS
Total Revenue
------660.00K420K-1.02M89M
(-18.27%)
108M
(+5.61%)
103M
(+4.55%)
98M
(+37.51%)
71M
(+226.31%)
22M
(+6154.29%)
350K---280K--
Operating Expenses
Research And Development
28M
(+30.17%)
21M
(+6.80%)
20M
(-27.04%)
27M
(+23.06%)
22M
(-3.36%)
23M
(+7.77%)
21M
(-9.04%)
23M
(-36.22%)
37M
(-18.48%)
45M
(+49.50%)
30M
(+3.44%)
29M
(+20.05%)
24M
(+6.05%)
23M
(-8.43%)
25M
(+2.68%)
24M
(+13.05%)
21M
(+60.27%)
13M
(+4.20%)
13M
(+17.57%)
11M
(+59.33%)
6.86M
Selling General And Administrative
16M
(+5.07%)
15M
(-4.82%)
16M
(+3.39%)
16M
(-0.26%)
16M
(-8.30%)
17M
(-4.09%)
18M
(-17.64%)
22M
(-62.52%)
58M
(+10.57%)
52M
(+7.22%)
49M
(+12.28%)
43M
(-1.41%)
44M
(+7.76%)
41M
(+36.41%)
30M
(-0.17%)
30M
(+13.81%)
26M
(+76.61%)
15M
(+44.15%)
10M
(+35.12%)
7.66M
(+27.67%)
6.00M
Operating Expenses
44M
(+19.62%)
37M
(+1.58%)
36M
(-15.94%)
43M
(+13.39%)
38M
(-5.48%)
40M
(-47.44%)
76M
(+1.09%)
75M
(-64.29%)
211M
(+97.87%)
107M
(+26.85%)
84M
(+7.63%)
78M
(+6.18%)
73M
(+10.53%)
66M
(+20.81%)
55M
(+1.44%)
54M
(+13.47%)
48M
(+68.82%)
28M
(+22.07%)
23M
(+24.80%)
19M
(+44.44%)
13M
Depreciation And Amortization
100K
(-72.97%)
370K--160K
(-72.88%)
590K--320K
(-63.64%)
880K--200K
(-55.56%)
450K--40K
(0.00%)
40K--10K
Operating Income
Operating Income
-43.78M
(+19.62%)
-36.60M
(+1.58%)
-36.03M
(-15.94%)
-42.86M
(+13.39%)
-37.80M
(-7.01%)
-40.65M
(-46.27%)
-75.66M
(-0.83%)
-76.29M
(-37.53%)
-122.13M1.93M
(-89.69%)
19M
(-7.33%)
20M-2.05M
(-95.40%)
-44.59M
(-18.45%)
-54.68M
(+0.79%)
-54.25M
(+13.47%)
-47.81M
(+68.88%)
-28.31M
(+23.52%)
-22.92M
(+23.29%)
-18.59M
(+44.44%)
-12.87M
Ebit
-43.78M
(+19.62%)
-36.60M
(+1.58%)
-36.03M
(-15.94%)
-42.86M
(+13.39%)
-37.80M
(-7.01%)
-40.65M
(-46.27%)
-75.66M
(-0.83%)
-76.29M
(-37.53%)
-122.13M1.93M
(-89.69%)
19M
(-7.33%)
20M-2.05M
(-95.40%)
-44.59M
(-18.45%)
-54.68M
(+0.79%)
-54.25M
(+13.47%)
-47.81M
(+68.88%)
-28.31M
(+23.52%)
-22.92M
(+23.29%)
-18.59M
(+44.44%)
-12.87M
EBITDA
-43.68M
(+11.17%)
-39.29M
(+14.25%)
-34.39M
(-17.01%)
-41.44M
(+10.07%)
-37.65M
(-19.22%)
-46.61M
(-35.89%)
-72.70M
(0.00%)
-72.70M
(-40.32%)
-121.81M
(+2502.78%)
-4.68M22M
(-6.66%)
24M-1.85M
(-95.92%)
-45.30M
(-15.92%)
-53.88M
(-0.02%)
-53.89M
(+12.79%)
-47.78M
(+93.36%)
-24.71M
(+6.78%)
-23.14M
(+5.57%)
-21.92M
(+70.45%)
-12.86M
Other Income / Expenses
Interest Income
2.57M
(-21.88%)
3.29M
(+80.77%)
1.82M
(-7.14%)
1.96M
(-12.11%)
2.23M
(-3.88%)
2.32M
(-25.16%)
3.10M
(-23.83%)
4.07M
(-6.00%)
4.33M
(-0.92%)
4.37M
(+4.55%)
4.18M
(+7.46%)
3.89M
(+4.57%)
3.72M
(+17.72%)
3.16M
(+426.67%)
600K
(+50.00%)
400K
(+207.69%)
130K
(+333.33%)
30K---
Net Interest Income
2.57M
(-21.88%)
3.29M
(+80.77%)
1.82M
(-7.14%)
1.96M
(-12.11%)
2.23M
(-3.88%)
2.32M
(-25.16%)
3.10M
(-23.83%)
4.07M
(-6.00%)
4.33M
(-0.92%)
4.37M
(+4.55%)
4.18M
(+7.46%)
3.89M
(+4.57%)
3.72M
(+17.72%)
3.16M
(+426.67%)
600K
(+50.00%)
400K
(+207.69%)
130K
(+333.33%)
30K---
Other Non Operating Income
-70.00K
(-90.00%)
-700.00K
(+288.89%)
-180.00K
(-67.27%)
-550.00K
(+66.67%)
-330.00K
(-72.73%)
-1.21M
(+764.29%)
-140.00K
(-70.83%)
-480.00K
(-36.00%)
-750.00K
(+13.64%)
-660.00K
(+34.69%)
-490.00K
(+512.50%)
-80.00K
(-69.23%)
-260.00K
(-52.73%)
-550.00K200K-40.00K
(+100.00%)
-20.00K
(-60.00%)
-50.00K
(-78.26%)
-230.00K
(+666.67%)
-30.00K260K
Net Income
Income Before Tax
--32.95M
(-4.19%)
-34.39M
(-17.01%)
-41.44M
(+15.40%)
-35.91M
(-5.95%)
-38.18M
(-47.48%)
-72.70M
(0.00%)
-72.70M
(-38.68%)
-118.55M6.48M
(-71.08%)
22M
(-6.66%)
24M
(+1615.00%)
1.40M-42.12M
(-21.83%)
-53.88M
(-0.02%)
-53.89M
(+12.98%)
-47.70M
(+68.31%)
-28.34M
(+22.47%)
-23.14M
(+5.57%)
-21.92M
(+50.96%)
-14.52M
Income Tax Expense
-50K----630.00K--240K
(-86.29%)
1.75M
(+15.13%)
1.52M
(-21.24%)
1.93M-170.00K580K-120.00K170K
(+13.33%)
150K----
Net Income From Continuing Operations
-41.28M
(+25.09%)
-33.00M
(-4.04%)
-34.39M
(-17.01%)
-41.44M
(+15.40%)
-35.91M
(-4.37%)
-37.55M
(-48.35%)
-72.70M
(0.00%)
-72.70M
(-38.80%)
-118.79M4.73M
(-77.36%)
21M
(-5.35%)
22M
(+1305.73%)
1.57M-42.70M
(-20.57%)
-53.76M
(-0.57%)
-54.07M
(+13.00%)
-47.85M
(+68.84%)
-28.34M
(+22.47%)
-23.14M
(+5.57%)
-21.92M
(+50.96%)
-14.52M
Net Income
-41.28M
(+25.09%)
-33.00M
(-4.04%)
-34.39M
(-17.01%)
-41.44M
(+15.40%)
-35.91M
(-4.37%)
-37.55M
(-48.35%)
-72.70M
(0.00%)
-72.70M
(-38.80%)
-118.79M4.73M
(-77.36%)
21M
(-5.35%)
22M
(+1305.73%)
1.57M-42.70M
(-20.57%)
-53.76M
(-0.57%)
-54.07M
(+13.00%)
-47.85M
(+68.84%)
-28.34M
(+22.47%)
-23.14M
(+5.57%)
-21.92M
(+50.96%)
-14.52M
Comprehensive Income Net Of Tax
-41.45M
(-71.26%)
-144.24M
(+322.74%)
-34.12M
(-16.56%)
-40.89M
(+14.19%)
-35.81M
(-88.14%)
-302.03M
(+319.66%)
-71.97M
(-1.03%)
-72.72M
(-38.93%)
-119.07M50M
(+138.11%)
21M
(-5.32%)
22M
(+1208.33%)
1.68M-198.47M
(+265.64%)
-54.28M
(+0.31%)
-54.11M
(+12.71%)
-48.01M
(-45.39%)
-87.92M
(+279.95%)
-23.14M
(+5.57%)
-21.92M
(+50.96%)
-14.52M